Beteiligungsmeldung

Molecular Partners AG

Gemeinsam gemeldeter Anteil

59.08%

Threshold

Crossed upwards

Timeline

Published

13.12.2014

Transaction

11.12.2014

Voting rights breakdown

Erworbene Stimmrechte59.08%
Veräusserte Stimmrechte0%
Unter dem Schwellenwert0%

Gemeldete wirtschaftlich Berechtigte · 7

Eine einzelne, gemeinsam eingereichte Meldung: Der Stimmrechtsanteil gilt für die gesamte Gruppe, nicht für jede Person.

Notice details

KategorieGroup of shareholders
BörseXSWX

Meldungs-ID

TBECB000A0

Beneficial owner

Index Ventures Associates IV Limited

Gemeldete Adresse

Index Ventures Associates IV Limited, St. Helier, Jersey JE4 9WG

Partial exercise of the overallotment option pursuant to the underwriting agreement dated October 7, 2014, between Molecular Partners Ltd., J.P. Morgan Securities plc (as global coordinator), UBS AG (as joint lead manager and together with J.P. Morgan Securities, the "Joint Bookrunners"), Cowen and Company, LLC (as co-manager) and Bank am Bellevue AG (as co-manager). Partial exercise triggered capital increase. - Index Ventures Associates IV Limited holds its shareholding through Index Venture IV (Jersey), L.P., Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. and Yucca (Jersey) SLP; Index Ventures Associates IV Limited is the managing general partner of the direct shareholders and manages and controls the voting rights. - Essex Woodlands Health Ventures LLC holds its shareholding through Essex Woodlands Health Ventures Fund VIII L.P., Essex Woodlands Health Ventures Fund VIII-A L.P. and Essex Woodlands Health Ventures Fund VIII-B L.P.; Essex Woodlands Health Ventures LLC is the general partner of the direct shareholders, and manages and controls the voting rights. - Johnson and Johnson holds its shareholding trough Johnson & Johnson Development Corporation; Johnson & Johnson is the direct parent company of Johnson & Johnson Development Corporation. - BB Biotech Ventures GP (Guernsey) Limited holds its shareholdings through BB Biotech Ventures II L.P.; BB Biotech Ventures GP (Guernsey) Limited is the general partner of BB Biotech Ventures II L.P. and manages and controls the voting rights. - Endeavour Partners GP Limited holds part of its shareholdings through Endeavour II (Guernsey) L.P.; Endeavour Parners GP Limited is the manager of the voting rights of Endeavour II (Guernsey) L.P.

Diese Zahlen fassen öffentliche Meldungen zusammen. Sie stellen keine Anlageberatung dar.

Quelle: SIX Exchange Regulation

insider24.ch

Verpassen Sie kein Marktsignal mehr

Pro-AlarmeE-Mail und Telegram nach Veröffentlichung
Unbegrenzt Unternehmen verfolgenUnbegrenzte Watchlist mit dem Pro-Plan
MontagsrückblickDas Wichtigste zu Ihren Werten zur Eröffnung